Learning to Treat COVID-19 — Clinical Trials and Developing Therapeutics During a Pandemic

The American Public Health Association and the National Academy of Medicine are sponsoring a webinar series exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. UNC School of Medicine's Myron Cohen, MD, is part of an expert panel June 24.

The tenth COVID-19 Conversations webinar will discuss how scientists are learning to treat COVID-19, including presentations on: how scientists have adapted clinical trials to respond to the restrictions and requirements of a pandemic response; best practices in clinical care for those with COVID-19 right now; and promising therapeutics and preventive drugs currently enrolled in clinical trials globally.

Here's the Expert Panel:

  • Carlos del Rio, MD (Moderator) — Distinguished Professor of Medicine, Emory University School of Medicine; Professor of Global Health and Epidemiology, Emory Rollins School of Public Health; Executive Associate Dean, Emory at Grady; Co-Director, Emory Center for AIDS Research
  • Judith Currier, MD — Professor of Medicine, UCLA Division of Infectious Diseases, Department of Medicine Division Chief, Infectious Diseases Associate Director, UCLA Clinical AIDS Research and Education (CARE) Center
  • Rajesh Gandhi, MD — Professor of Medicine, Harvard Medical School; Director of HIV Clinical Services and Education, Massachusetts General Hospital
  • Myron Cohen, MD — University of North Carolina Yeargan-Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology, and Director of the UNC Institute for Global Health & Infectious Diseases

Participants can earn 1.5 CPH, CME, CNE, or CHES continuing education credits.

Register here for the June 24 webinar, from 5 p.m. to 6:30 p.m. ET.

Filed under: ,